October 4, 2025 · Form 4 insider transaction
Megna Michael R bought 175 shares of Kiniksa Pharmaceuticals Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.